Search Results - "Mills, K.H.G."

P.1.40 Psychological stress increases production of IL-10 and IL-19: A role for the sympathetic neurotransmitter noradrenaline by Curtin, N.M, Connor, T.J, Mills, K.H.G

Get full text

Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines by Butt, A Q, Mills, K H G

“…Vaccines that promote protective adaptive immune responses have been successfully developed against a range of infectious diseases, and these are normally…”
Get full text

T cells in multiple sclerosis and experimental autoimmune encephalomyelitis by Fletcher, J.M, Lalor, S.J, Sweeney, C.M, Tubridy, N, Mills, K.H.G

“…Multiple sclerosis (MS) is a demyelinating inflammatory disorder of the central nervous system (CNS), which involves autoimmune responses to myelin antigens…”
Get full text

TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours by Conroy, H, Marshall, N A, Mills, K H G

“…Toll-like receptor (TLR) agonists are potent activators of innate immune responses, activating dendritic cell (DC) maturation and inflammatory cytokine…”
Get full text

Recombinant BCG Expressing LTAK63 Adjuvant induces Superior Protection against Mycobacterium tuberculosis by Nascimento, Ivan P., Rodriguez, Dunia, Santos, Carina C., Amaral, Eduardo P., Rofatto, Henrique K., Junqueira-Kipnis, Ana P., Gonçalves, Eduardo D. C., D’Império-Lima, Maria R., Hirata, Mario H., Silva, Celio L., Winter, Nathalie, Gicquel, Brigitte, Mills, Kingston H. G., Pizza, Mariagrazia, Rappuoli, Rino, Leite, Luciana C. C.

“…In order to develop an improved BCG vaccine against tuberculosis we have taken advantage of the adjuvant properties of a non-toxic derivative of Escherichia…”
Get full text

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants by Pizza, M., Giuliani, M.M., Fontana, M.R., Monaci, E., Douce, G., Dougan, G., Mills, K.H.G., Rappuoli, R., Del Giudice, G.

“…Most vaccines are still delivered by injection. Mucosal vaccination would increase compliance and decrease the risk of spread of infectious diseases due to…”
Get full text

Stable plastid transformation in lettuce (Lactuca sativa L.) by Lelivelt, C.L.C, McCabe, M.S, Newell, C.A, Snoo, C.B. de, Dun, K.M.P. van, Birch-Machin, I, Gray, J.C, Mills, K.H.G, Nugent, J.M

Get full text

Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles by Cahill, E.S., O'Hagan, D.T., Illum, L., Barnard, A., Mills, K.H.G., Redhead, K.

“…The intranasal (i.n.) immunization of mice with Bordetella pertussis filamentous haemagglutinin (FHA) either as a solution or incorporated in biodegradable…”
Get full text

Avirulent Semliki Forest virus replication and pathology in the central nervous system is enhanced in IL-12-defective and reduced in IL-4-defective mice: a role for Th1 cells in the protective immunity by Keogh, B, Atkins, G.J, Mills, K.H.G, Sheahan, B.J

“…Experimental infection of mice with avirulent Semliki Forest virus (SFV) has been used as a model of demyelinating disease in humans. A number of studies have…”
Get full text

Biodegradable microparticles for oral immunization by O'Hagan, D T, McGee, J P, Holmgren, J, Mowat, A M, Donachie, A M, Mills, K H, Gaisford, W, Rahman, D, Challacombe, S J

“…Ovalbumin (OVA) was entrapped in poly(lactide-co-glycolide) microparticles and administered to mice. Following intraperitoneal immunization, the microparticles…”
Get more information

The role of IFN-γ in preventing disseminating infection with Bordetella pertussis by Mahon, B.P., Griffin, F., Sheahan, B.J., Murphy, G., Mills, K.H.G.

Get full text

Parenteral and oral immunization with plasmid DNA expressing the HIV envelope protein: Induction of cellular immune responses by Moore, A., Adams, S., Jones, D.H., Farrar, G., Mills, K.H.G.

Get full text

Studies on the immunogenicity of Chinese hamster ovary cell-derived recombinant gp120 (HIV-1IIIB) by Page, M, Mills, K H, Schild, G C, Ling, C, Patel, V, McKnight, A, Barnard, A L, Dilger, P, Thorpe, R

“…Recombinant DNA-derived gp120 (HIV-1IIIB) expressed in chinese hamster ovary cells elicited specific humoral and cell-mediated immune responses in a variety of…”
Get more information

Protection against SIV infection in macaques by immunization with inactivated virus from the BK28 molecular clone, but not with BK28-derived recombinant env and gag proteins by Mills, K H, Page, M, Chan, W L, Kitchin, P, Stott, E J, Taffs, F, Jones, W, Rose, J, Ling, C, Silvera, P

“…Vaccination of cynomolgus macaques with beta-propiolactone inactivated SIVmacBK28 in Freund's adjuvant induced low but detectable levels of anti-SIV envelope…”
Get more information

Immunisation of macaques with SIV env recombinants: specificity of T cell and antibody responses and evaluation of protective efficacy by Mills, K H, Page, M, Kitchin, P, Chan, L, Jones, W, Silvera, P, Corcoran, T, Flanagan, B, Ling, C, Thiriart, C

“…Macaques were immunised with lentil lectin purified recombinant SIVmac (BK28) derived gp160 (rgp160) with or without live vaccinia (vac)-env (BK28) priming,…”
Get more information

Stimulated lymphoid cells of B lineage, but not plasma or myeloid cells, can express E receptor by Mills, K H, Cawley, J C

“…After culture with 20-30% autologous or allogeneic T cells and PHA, at least a proportion of the pathological cells from a variety of B-cell proliferations…”
Get more information